Evidence map›Paper›PMID 34667967›Full record

ArticleHeart rhythm O22021

Computational ECG mapping and respiratory gating to optimize stereotactic ablative radiotherapy workflow for refractory ventricular tachycardia.

Gordon Ho, Todd F Atwood, Andrew R Bruggeman, Kevin L Moore, Elliot McVeigh, Christopher T Villongco, Frederick T Han, Jonathan C Hsu, Kurt S Hoffmayer, Farshad Raissi and 10 more

Open access · goldAbstract read
In one paragraph

Article in Heart rhythm O2, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Pooled it
  3. Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Patient selection, ventricular tachycardia substrate delineation, and data transfer for stereotactic arrhythmia radioablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Gordon HoDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
Todd F AtwoodDepartment of Radiation Medicine, University of California San Diego, La Jolla, California.
Andrew R BruggemanDepartment of Radiation Medicine, University of California San Diego, La Jolla, California.
Kevin L MooreDepartment of Radiation Medicine, University of California San Diego, La Jolla, California.
Elliot McVeighDepartment of Bioengineering, University of California San Diego, La Jolla, California.
Christopher T VillongcoVektor Medical Inc, Carlsbad, California.
Frederick T HanDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
Jonathan C HsuDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
Kurt S HoffmayerDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
Farshad RaissiDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
Grace Y LinDepartment of Pathology, University of California San Diego, La Jolla, California.
Amir SchrickerDepartment of Cardiac Electrophysiology, Mills-Peninsula Medical Center, Sutter Health, Burlingame, California.
Christopher E WoodsDepartment of Cardiac Electrophysiology, Mills-Peninsula Medical Center, Sutter Health, Burlingame, California.
Joey P CheungDepartment of Radiation Oncology, Mills-Peninsula Medical Center, Sutter Health, Burlingame, California.
Al V TairaDepartment of Radiation Oncology, Mills-Peninsula Medical Center, Sutter Health, Burlingame, California.
Andrew McCullochDepartment of Bioengineering, University of California San Diego, La Jolla, California.
Ulrika Birgersdotter-GreenDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
Gregory K FeldDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
Arno J MundtDepartment of Radiation Medicine, University of California San Diego, La Jolla, California.
David E KrummenDepartment of Medicine-Cardiology, University of California San Diego, La Jolla, California.
University of California San Diego · USSutter Health · US

Funding

UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
The Cardiac Atlas ProjectR01HL121754 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCCULLOCH, ANDREW D., OMENS, JEFFREY H. · 2014 to 2023
$5.0M
American Heart Association-American Stroke Association 19CDA34760021NCATS NIH HHS KL2 TR001444NHLBI NIH HHS R01 HL121754
6 · The paper itself

Abstract

backgroundStereotactic ablative radiotherapy (SAbR) is an emerging therapy for refractory ventricular tachycardia (VT). However, the current workflow is complicated, and the precision and safety in patients with significant cardiorespiratory motion and VT targets near the stomach may be suboptimal.

objectiveWe hypothesized that automated 12-lead electrocardiogram (ECG) mapping and respiratory-gated therapy may improve the ease and precision of SAbR planning and facilitate safe radiation delivery in patients with refractory VT.

methodsConsecutive patients with refractory VT were studied at 2 hospitals. VT exit sites were localized using a 3-D computational ECG algorithm noninvasively and compared to available prior invasive mapping. Radiotherapy (25 Gy) was delivered at end-expiration when cardiac respiratory motion was ≥0.6 cm or targets were ≤2 cm from the stomach.

resultsIn 6 patients (ejection fraction 29% ± 13%), 4.2 ± 2.3 VT morphologies per patient were mapped. Overall, 7 out of 7 computational ECG mappings (100%) colocalized to the identical cardiac segment when prior invasive electrophysiology study was available. Respiratory gating was associated with smaller planning target volumes compared to nongated volumes (71 ± 7 vs 153 ± 35 cc,

conclusionsA workflow including computational ECG mapping and protocol-guided respiratory gating is feasible, is safe, and may improve the ease of SAbR planning. Studies to validate this workflow in larger populations are required.

Indexed as

AblationCardiac computed tomographyElectrocardiographyNoninvasive mappingStereotactic ablative radiotherapyVentricular tachycardia

Identifiers

PMID34667967
PMCPMC8505208
OpenAlexW3197103446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.